Autoimmune glial fibrillary acidic protein astrocytopathy: A novel meningoencephalomyelitis

JAMA Neurology

Volumn 73, Issue 11, 2016, Pages 1297-1307

  Fang, Boyan ^a   McKeon, Andrew ^a   Hinson, Shannon R ^a   Kryzer, Thomas J ^a   Pittock, Sean J ^a   Aksamit, Allen J ^a   Lennon, Vanda A ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; CORTICOSTEROID; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN G; INTERMEDIATE FILAMENT PROTEIN; BIOLOGICAL MARKER;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; ASTROCYTE; AUTOIMMUNITY; BLOOD ANALYSIS; BRAIN DISEASE; CANCER RISK; CD8+ T LYMPHOCYTE; CEREBELLAR ATAXIA; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COLON CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOL; DISEASE MODEL; DRUG MEGADOSE; ESOPHAGUS CARCINOMA; FEMALE; HEADACHE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MELANOMA; MENINGOENCEPHALITIS; MOUSE; MYELITIS; MYELOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLITIS; PLEOMORPHIC ADENOMA; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RELAPSE; STOMACH CARCINOMA; TERATOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; BLOOD; CEREBROSPINAL FLUID; HEK293 CELL LINE; IMMUNOLOGY; MIDDLE AGED; NEUROLOGIC DISEASE; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; RECURRENT DISEASE; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ASTROCYTES; AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; BIOMARKERS; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; MALE; MENINGOENCEPHALITIS; MIDDLE AGED; MYELITIS; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RECURRENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84996843650     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2016.2549     Document Type: Article

References (36)

1. Iorio R, Lennon VA. Neural antigen-specific autoimmune disorders. Immunol Rev. 2012;248(1): 104-121.
2. Dalmau J, Rosenfeld MR. Autoimmune encephalitis update. Neuro Oncol. 2014;16(6): 771-778.
3. Crisp SJ, Kullmann DM, Vincent A. Autoimmune synaptopathies. Nat Rev Neurosci. 2016;17(2):103-117.
4. Pittock SJ, Kryzer TJ, Lennon VA. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome. Ann Neurol. 2004;56(5): 715-719.
5. Horta ES, Lennon VA, Lachance DH, et al. Neural autoantibody clusters aid diagnosis of cancer. Clin Cancer Res. 2014;20(14):3862-3869.
6. Meeusen JW, Klein CJ, Pirko I, et al. Potassium channel complex autoimmunity induced by inhaled brain tissue aerosol. Ann Neurol. 2012;71(3):417-426.
7. Higgins DM,Wang R, Milligan B, et al. Brain tumor stem cell multipotency correlates with nanog expression and extent of passaging in human glioblastoma xenografts. Oncotarget. 2013;4(5): 792-801.
8. Caselli RJ, Boeve BF, Scheithauer BW, O'Duffy JD, Hunder GG. Nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM): A reversible form of encephalopathy. Neurology. 1999;53(7):1579-1581.
9. Aksamit AJ,Weinshenker B, Parisi J. Chronic microglial encephalomyelitis (CME). Ann Neurol. 2012;72(suppl 16):S110.
10. Porchet R, Probst A, Bouras C, Dráberová E, Dráber P, Riederer BM. Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease. Proteomics. 2003;3(8):1476-1485.
11. Caselli RJ, Scheithauer BW, Bowles CA, et al. The treatable dementia of Sjögren's syndrome. Ann Neurol. 1991;30(1):98-101.
12. Hoffman Snyder C, Mishark KJ, Caviness JN, Drazkowski JF, Caselli RJ. Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease. Arch Neurol. 2006;63(5):766-768.
13. Matsuki N, Fujiwara K, Tamahara S, et al. Prevalence of autoantibody in cerebrospinal fluids from dogs with various CNS diseases. J Vet Med Sci. 2004;66(3):295-297.
14. Toda Y, Matsuki N, ShibuyaM, Fujioka I, Tamahara S, Ono K. Glial fibrillary acidic protein (GFAP) and anti-GFAP autoantibody in canine necrotising meningoencephalitis. Vet Rec. 2007;161 (8):261-264.
15. ShibuyaM, Matsuki N, Fujiwara K, et al. Autoantibodies against glial fibrillary acidic protein (GFAP) in cerebrospinal fluids from Pug dogs with necrotizing meningoencephalitis. J Vet Med Sci. 2007;69(3):241-245.
16. Miyake H, Inoue A, TanakaM, Matsuki N. Serum glial fibrillary acidic protein as a specific marker for necrotizing meningoencephalitis in Pug dogs. J Vet Med Sci. 2013;75(11):1543-1545.
17. Uchida K, Hasegawa T, Ikeda M, Yamaguchi R, Tateyama S. Detection of an autoantibody from Pug dogs with necrotizing encephalitis (Pug dog encephalitis). Vet Pathol. 1999;36(4):301-307.
18. Suzuki M, Uchida K, Morozumi M, et al. A comparative pathological study on canine necrotizing meningoencephalitis and granulomatous meningoencephalomyelitis. J Vet Med Sci. 2003;65(11):1233-1239.
19. Young BD, Levine JM, Fosgate GT, et al. Magnetic resonance imaging characteristics of necrotizing meningoencephalitis in Pug dogs. J Vet Intern Med. 2009;23(3):527-535.
20. Lennon VA, Lambert EH, Whittingham S, Fairbanks V. Autoimmunity in the Lambert-Eaton myasthenic syndrome. Muscle Nerve. 1982;5(9S): S21-S25.
21. Brickshawana A, Hinson SR, Romero MF, et al. Investigation of the KIR4.1 potassium channel as a putative antigen in patients with multiple sclerosis: A comparative study. Lancet Neurol. 2014;13(8): 795-806.
22. Titulaer MJ, Höftberger R, Iizuka T, et al. Overlapping demyelinating syndromes and anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol. 2014;75(3):411-428.
23. Finke C, Mengel A, Prüss H, StöckerW, Meisel A, Ruprecht K. Anti-NMDAR encephalitis mimicking HaNDL syndrome. Cephalalgia. 2014;34 (12):1012-1014.
24. McKeon A, Lennon VA, LaChance DH, Klein CJ, Pittock SJ. Striational antibodies in a paraneoplastic context. Muscle Nerve. 2013;47(4):585-587.
25. Calame JJ, Schaberg A. Solid teratomas and mixed müllerian tumors of the ovary: A clinical, histological, and immunocytochemical comparative study. Gynecol Oncol. 1989;33(2):212-221.
26. Spaulding R, Alatassi H, StewartMetzinger D, Moghadamfalahi M. Ependymoma and carcinoid tumor associated with ovarian mature cystic teratoma in a patient with multiple endocrine neoplasia I. Case Rep Obstet Gynecol. 2014;2014: 712657.
27. Stead RH, Qizilbash AH, Kontozoglou T, Daya AD, Riddell RH. An immunohistochemical study of pleomorphic adenomas of the salivary gland: glial fibrillary acidic protein-like immunoreactivity identifies a majormyoepithelial component. Hum Pathol. 1988;19(1):32-40.
28. Turhan OI, Aydin NE, Sariyüce O. Adenosquamous carcinoma of the prostate. Int Urol Nephrol. 1999;31(1):89-93.
29. Iyengar B, Singh AV. Patterns of neural differentiation in melanomas. J Biomed Sci. 2010;17:87.
30. Chojnacki AK, Mak GK,Weiss S. Identity crisis for adult periventricular neural stem cells: subventricular zone astrocytes, ependymal cells or both? Nat Rev Neurosci. 2009;10(2):153-163.
31. Middeldorp J, Hol EM. GFAP in health and disease. Prog Neurobiol. 2011;93(3):421-443.
32. Mamber C, KamphuisW, Haring NL, Peprah N, Middeldorp J, Hol EM. GFAPδ expression in glia of the developmental and adolescent mouse brain. PLoS One. 2012;7(12):e52659.
33. AlbertML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med. 1998;4(11):1321-1324.
34. Sasaki K, Bean A, Shah S, et al. Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells. J Immunol. 2014;192(7):3029-3042.
35. Pittock SJ, Lucchinetti CF, Lennon VA. Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments. Ann Neurol. 2003;53(5):580-587.
36. Buckanovich RJ, Posner JB, Darnell RB. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron. 1993;11(4): 657-672.